Rare Disease

Latest News

Greater Understanding Necessary in Treatment of Periorbital Facial Necrotizing Fasciitis, Review Argues
Greater Understanding Necessary in Treatment of Periorbital Facial Necrotizing Fasciitis, Review Argues

November 29th 2023

With greater understanding of this rare pathology and its signs and symptoms, review authors believe this understanding could prompt early and necessary intervention.

FDA Grants Priority Review of Abeona’s Pz-cel BLA for Recessive DEB
FDA Grants Priority Review of Abeona’s Pz-cel BLA for Recessive DEB

November 28th 2023

FDA Grants Breakthrough Therapy Designation to QTORIN Rapamycin for Microcystic Lymphatic Malformations
FDA Grants Breakthrough Therapy Designation to QTORIN Rapamycin for Microcystic Lymphatic Malformations

November 16th 2023

Living With Pachyonychia Congenita: Patient Perspectives and Activism
Living With Pachyonychia Congenita: Patient Perspectives and Activism

October 12th 2023

FDA Clears IND for KYV-101 for the Treatment of Scleroderma
FDA Clears IND for KYV-101 for the Treatment of Scleroderma

October 11th 2023

Video Interviews
Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

View More

More News

© 2023 MJH Life Sciences

All rights reserved.